BioSpace News Archive

BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced the appointment of Christopher Boyer as Vice President of Global Marketing.

Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce a proposed offering of 25,000,000 units (the “Units”) at an offering price of $0.20 per Unit (the “Issue Price”), for aggregate gross proceeds of up to $5,000,000 (the “Offering”).

Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Jefferies Virtual Healthcare Conference, which is being held June 2-4, 2020 . Encompass Health President and Chief Executive Officer Mark Tarr and Encompass Health Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a

ARTMS Inc . a global leader in developing technology that transforms the production of the world’s most-used diagnostic imaging isotopes, today announced that it has raised US$19 million in a Series A financing. The investment was led by New York based Deerfield Management Company with continued investment from Vanco

Presentation reports safety and efficacy results of INT230-6 administered alone and in combination with pembrolizumab (Keynote A10 study); safety of combination was comparable to INT230-6 monotherapy Following dosing INT230-6 alone, 13 patients had stable disease for greater than 6 months and 10 subjects had regression of uninjected tumors (abscopal effects) WESTPORT, Conn.--( BUSINESS WIRE )-- Intensity Therapeutics, Inc. , a clinical-stage

Ocular Therapeutix™, Inc. announced the pricing of an underwritten public offering of 8,181,819 shares of its common stock at a public offering price of $5.50 per share for gross proceeds of approximately $45 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

Latest investment round includes Benhamou Global Ventures, Honeywell Ventures, Morpheus Ventures and Zebra Ventures to expand TAGNOS’ platform [20-May-2020] ALISO VIEJO, Calif. , May 20, 2020 /PRNewswire/ -- TAGNOS, a developer of workflow orchestration software for hospital operations, today announced investments from leading technology companies to expand and optimi

eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs, tissues, and cells to address the global organ shortage, today announced the acquisition of the assets and operations of ICBiotec (“ICB”), one of its key production partners.

Biocept, Inc . (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that Michael W. Nall , Biocept President and CEO, will participate on the panel " COVID-19 Testing & Susceptibi

Genetron Holdings Limited, a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces with DARUI.